<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: hiv therapy</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>HIV no barrier to getting liver transplant, study finds</title>
   	 <description>(HealthDay)—Liver transplants to treat a common type of liver cancer are a viable option for people infected with HIV, according to new research.</description>
     <link>http://medicalxpress.com/news/2013-05-hiv-barrier-liver-transplant.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Fri, 17 May 2013 12:40:01 EST</pubDate>
	 <guid isPermaLink="false">news288009467</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/hivnobarrier.jpg" width="90" height="90" />
</item>
<item>
     <title>HIV therapy just got easier: Fewer drugs may be needed for treatment-experienced patients</title>
   	 <description>A new multi-site study reveals patients with drug-resistant HIV can safely achieve viral suppression – the primary goal of HIV therapy – without incorporating the traditional class of HIV medications into their treatment regimen. Karen Tashima, M.D., director of the HIV Clinical Trials Program at The Miriam Hospital, served as study chair.</description>
     <link>http://medicalxpress.com/news/2013-03-hiv-therapy-easier-drugs-treatment-experienced.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 07 Mar 2013 11:42:10 EST</pubDate>
	 <guid isPermaLink="false">news281878922</guid>
	 
</item>
<item>
     <title>Study finds incentive price for reducing HIV risk in Mexico</title>
   	 <description>Studies have found that conditional cash transfer programs, in which governments pay citizens if they consistently practice societally beneficial behaviors, have improved pediatric health care and education in Mexico, increased HIV testing in Malawi, and reduced sexually transmitted infections in Tanzania. Public health researchers therefore investigated whether the idea could be applied to HIV risk behaviors among gay men and male sex workers in Mexico City. A new study reports not only that some members of those populations would change behavior for conditional cash payments, but the exact prices they would accept.</description>
     <link>http://medicalxpress.com/news/2013-02-incentive-price-hiv-mexico.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 04 Feb 2013 11:31:28 EST</pubDate>
	 <guid isPermaLink="false">news279199881</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/studyfindsin.jpg" width="90" height="90" />
</item>
<item>
     <title>Patient satisfaction leads to better HIV care</title>
   	 <description>In a study of patients at two HIV clinics in the Houston area, researchers at Baylor College of Medicine and the Michael E. DeBakey Veterans Affairs Medical Center found that those who were satisfied with the care they received had higher adherence to care and higher retention rates. Their report appears today in PLOS ONE.</description>
     <link>http://medicalxpress.com/news/2013-01-patient-satisfaction-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 30 Jan 2013 17:13:42 EST</pubDate>
	 <guid isPermaLink="false">news278788362</guid>
	 
</item>
<item>
     <title>Potential drug molecule shows enhanced anti-HIV activity</title>
   	 <description>Researchers from Munich and Naples have shown that minimal modification of a synthetic peptide with anti-HIV activity results in a new compound with more than two orders of magnitude higher binding affinity to the chemokine receptor CXCR4 and greatly improved anti-HIV activity. This could be a step toward the design of new, more effective drugs against AIDS, inflammatory diseases, and some forms of cancer.</description>
     <link>http://medicalxpress.com/news/2012-08-potential-drug-molecule-anti-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 09 Aug 2012 11:30:48 EST</pubDate>
	 <guid isPermaLink="false">news263730642</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/1-potentialdru.jpg" width="90" height="92" />
</item>
<item>
     <title>Study finds HIV-positive young men at risk of low bone mass</title>
   	 <description>Young men being treated for HIV are more likely to experience low bone mass than are other men their age, according to results from a research network supported by the National Institutes of Health. The findings indicate that physicians who care for these patients should monitor them regularly for signs of bone thinning, which could foretell a risk for fractures. The young men in the study did not have HIV at birth and had been diagnosed with HIV an average of two years earlier.</description>
     <link>http://medicalxpress.com/news/2012-06-hiv-positive-young-men-bone-mass.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 19 Jun 2012 15:07:23 EST</pubDate>
	 <guid isPermaLink="false">news259337226</guid>
	 
</item>
<item>
     <title>When prophecy fails: How to better predict success in HIV prevention clinical trials</title>
   	 <description>New research from the University of North Carolina at Chapel Hill schools of medicine and pharmacy may help explain the failure of some recent clinical trials of prevention of HIV infection, compared to the success of others that used the same drugs.</description>
     <link>http://medicalxpress.com/news/2011-12-prophecy-success-hiv-clinical-trials.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 07 Dec 2011 14:25:29 EST</pubDate>
	 <guid isPermaLink="false">news242490246</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/whenprophecy.jpg" width="90" height="90" />
</item>
<item>
     <title>Double duty: Anti-HIV topical gel also protects against herpes virus</title>
   	 <description>HIV infection is commonly associated with other sexual infections, such as herpes simplex virus (HSV). Infection with HSV facilitates the risk of HIV infection and negatively impacts the clinical course of HIV disease. Therefore, it would be highly beneficial to identify multi-faceted microbicide compounds that are efficient against HIV-1 and other sexually transmitted infections.</description>
     <link>http://medicalxpress.com/news/2011-10-duty-anti-hiv-topical-gel-herpes.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 19 Oct 2011 12:36:08 EST</pubDate>
	 <guid isPermaLink="false">news238246558</guid>
	 
</item>


</channel>
</rss>
